RxDoctor Payments Data

Patrick Thomae, DO

Family Medicine · Evans, GANPI 1972898476

Payments from drug & device makers

$725in general payments, 2019–2025

Across 30 payments — averaging $24.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$237
  • Intuitive Surgical$129
  • Bayer$123
  • Merck$65
  • Exact Sciences$41
  • Boston Scientific$27
  • plus $103 from 6 others

What the payments were for

  • Food & beverage$725100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$725 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$152,750
Medicare patients
348
Services billed
3,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide126$170,780
JardianceEmpagliflozin38$62,140
EliquisApixaban64$51,323
MounjaroTirzepatide38$44,756
JanuviaSitagliptin Phosphate15$19,533
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$18,683
ShingrixVaricella-Zoster Ge/As01b/Pf71$15,880
ArexvyRsvpref3 Antigen/As01e/Pf47$14,435
XareltoRivaroxaban14$10,141
TrulicityDulaglutide11$10,099
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,578
Boostrix TdapDiphth,pertuss(Acell),tet Vac56$3,838
Albuterol Sulfate HfaAlbuterol Sulfate92$3,314
Atorvastatin Calcium393$2,726
Wixela InhubFluticasone Propion/Salmeterol16$2,621

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$237$51,32364 claims
GSKTrelegy Ellipta, Shingrix, Arexvy$13$48,998134 claims
MerckJanuvia$65$19,53315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Evans

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →